Meanwhile, the coefficient was not significant in the policy implementation year but became significantly positive in the first post-policy period (t+1) and exhibited an increasing trend thereafter.
← all excerpts
Impact of China's national drug price negotiation on pharmaceutical firms' innovation activities.
1
—
—